cardioselectivity

car·di·o·se·lec·tiv·i·ty

(kar'dē-ō-sĕ-lek-tiv'i-tē),
The relatively predominant cardiovascular pharmacologic effect of a drug with multipharmacologic effects; used especially when describing beta-blocking agents.
Farlex Partner Medical Dictionary © Farlex 2012

car·di·o·se·lec·tiv·i·ty

(kahr'dē-ō-sĕ-lek-tiv'i-tē)
The relatively predominant cardiovascular pharmacologic effect of a drug with multipharmacologic effects; used especially when describing beta-blocking agents.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
Mentioned in ?
References in periodicals archive ?
Cruickshank, "The clinical importance of cardioselectivity and lipophilicity in beta blockers," American Heart Journal, vol.
Pharmacological Hypotension as a Cause of Delirious Mania in a Patient with Bipolar Disorder
In conclusion, cardioselectivity is paramount, and therefore metoprolol, bisoprolol and in particular nebivolol should be the first choice treatment.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEART FAILURE: CLOSER THAN CLOSE
Cardioselectivity varies between agents with the bisoprolol among the most selective.
The use of reversibility percent in spirometric assessment of chronic obstructive pulmonary diseases for the detrimental effect of 3rd generation beta-blockers
The first factor is cardioselectivity. These agents, which include bisoprolol, metoprolol, atenolol, and acebutolol, are thought to selectively target the beta-receptors in the cardiovascular system and, thus, are safer to use in patients with asthma or chronic obstructive pulmonary disease due to the fact that exacerbations occur when the beta-1 receptors found in the lungs are blocked.
Antihypertensive medications and renal disease. (Medication Review)

Medical browser ?
Full browser ?